One gene, two paths: Opposite synaptic defects linked to same intellectual disability
A research team led by Dr. Sheng Nengyin of the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences has reframed ZC4H2-associated rare disorder (ZARD)—a disorder marked by intellectual disability, developmental delays, muscle weakness and other neurological or physical abnormalities—as a "disease spectrum" rather than a condition driven by a single mechanism.
A research team led by Dr. Sheng Nengyin at the Kunming Institute of Zoology has discovered that different mutations in the same gene, ZC4H2, can cause nearly identical intellectual disability in patients through opposite synaptic mechanisms. Previously, ZC4H2 was believed to only impact excitatory synaptic activity, but the new study reveals that it also regulates inhibitory GABA receptor subunits.
The team created two knock-in mouse models with representative patient mutations, showing both groups had comparable cognitive deficits, including impaired novel-object recognition and social memory loss. However, their synaptic readouts differed: one model exhibited weakened GABAergic inhibitory transmission and impaired inhibitory long-term potentiation, while the other showed heightened AMPAR-mediated excitatory transmission and impaired excitatory LTP.
The researchers traced this divergence to two different E3 ubiquitin ligase pathways, with one mutant interacting with MKRN2 to destabilize GABA receptors and the other interacting with RNF220 to lower ubiquitination of AMPA receptors. Genetic rescue experiments confirmed that these specific interactions were responsible for the distinct synaptic defects.
The study also demonstrated that mutation-specific drugs, such as the GABA agonist muscimol and AMPAR antagonist perampanel, could rescue only the affected mice. This suggests that intervention for ZC4H2-associated intellectual disability should be tailored to the specific mutation rather than relying solely on the diagnosis.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
